Ghassan Abou-Alfa: Honored to Contribute to OncoDaily Teaching Effort on Biliary Cancers
Ghassan Abou-Alfa/genosciencepharma.com

Ghassan Abou-Alfa: Honored to Contribute to OncoDaily Teaching Effort on Biliary Cancers

Ghassan Abou-Alfa, Medical Oncologist at Memorial Sloan Kettering Cancer Center, shared a post by OncoDaily on X, adding:

“It was a great honor and delight for Memorial Sloan Kettering Cancer Center,MSK Department of Medicine, Ghassan Abou-Alfa and Harding JJMD to join this superb teaching effort.

Thanks OncoDaily for the opportunity.

Quoting OncoDaily’s post:

How I Treat Gallbladder and Bile Duct Cancer in 2026 | OncoDaily Virtual Summit

The Gallbladder and Bile Duct Cancer Summit 2026, organized by OncoDaily, brought together international experts to examine evolving clinical strategies and innovation shaping the management of gallbladder and biliary tract cancers.

During this session, Ghassan Abou-Alfa, James J Harding, Vinay Kumar Kapoor and Thatcher Heumann shared expert perspectives on contemporary systemic therapy for biliary tract cancers, the fundamental ‘Ten Commandments’ guiding gallbladder cancer management, practical approaches to treating gallbladder cancer in clinical practice, and emerging HER2- and RAS-targeted therapies shaping the future of hepatobiliary oncology.

Join the live conversation.”

Ghassan Abou-Alfa: Honored to Contribute to OncoDaily Teaching Effort on Biliary Cancers

Other articles featuring Ghassan Abou-Alfa on OncoDaily.